CSI Market
Sign In | Register

Blue Water Vaccines Inc (BWV) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access BWV quarterly Cash Flow →
Cash flow patterns shown here provide context for understanding Blue Water Vaccines Inc's ability to sustain operations and capital deployment.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022)
Operating Activities
Income-29.56
Depreciation & amortization0.03
Amortization of Other Assets0.12
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Goodwill, Impairment Loss11.51
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.07
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment-0.02
Share-based Compensation-0.50
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants-5.38
Amortization Of Debt Discount Related Party0.40
Loss On Related Party Receivable-
Fair Value Of Subscription Agreement Liability-
Interest Accrued On Note Payable-
Interest Accrued On Note Payable Related Party-
Impairment Of E N T A D F I Assets3.53
Amortization Of Deferred Offering Costs0.37
Gain Loss Related To Litigation Settlement-0.01
Change In Fair Value Of Subscription Agreement Liability3.26
Loss On Extinguishment Of Notes Payable-
Loss Extinguishment Of Preferred Stock-
Change In Fair Value Of Subscription Agreement Liability Related Party-
Gain On Forgiveness Of Accounts Payable-
Income taxes0.30
Losses/ -gains on Investments net0.00
Accounts Receivable0.32
Increase (Decrease) in Accounts Payable-1.09
Increase (Decrease) in Accrued Liabilities-0.58
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.35
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-9.68
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Receivable From Related Parties-
Payments to Acquire Restricted Certificates of Deposit0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net1.34
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-7.11
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock6.39
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock7.59
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents4.55
Deferred Offering Costs-
Debt Conversion Converted Instrument Amount-
Payments For Purchase Of Treasury Shares-
Proceeds From Issuance Of Common Stock In Initial Public Offering Net Of Underwriting Discount-
Proceeds From Exercise of Preferred Investment Options Net0.92
Cash In Lieu Of Shares0.00
Proceeds From Issuance Of Series E Preferred Stock And Warrants-
Proceeds From Issuance Of Series C Preferred Stock And Warrants-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities14.45
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-9.68
Total Cash Flow4.57
4 historic quarters locked

Sign in to unlock the full Blue Water Vaccines Inc cash flow history.

Sign In Create Free Account

About Onconetix Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-26-027725

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License